• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsUltragenyx Pharmaceutical
    Picture of Ultragenyx Pharmaceutical logo

    RARE — Ultragenyx Pharmaceutical News Story

    $15.950.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSucker Stock
    • Market Cap
      $1.57bn
    • Enterprise Value
      $2.43bn
    • Revenue
      $673.00m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • RARE Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    RARE Dividends
    All News

    NASDAQ TRADE HALT HALT NEWS PENDING AT 08:25 AM

    Picture of Ultragenyx Pharmaceutical logoUltragenyx Pharmaceutical
    29/12/2025 13:25
    NASDAQ TRADE HALT  RARE.O  HALT NEWS PENDING AT 08:25 AM
    

    Recent news on Ultragenyx Pharmaceutical

    See all news
    • Brief: Ultragenyx Pharmaceutical Enters Settlement Agreement With Navinta On Dojolvi Patent Litigation - SEC Filing

      Mon 14:22
    • Ultragenyx gains on $210 million US FDA voucher sale

      07/10/2026 15:06
    • Brief: Ultragenyx Pharmaceutical - Under Deal With U.S. Department Of Health Co To Pay 20% Of Prv Sale Proceeds To Nih

      07/10/2026 14:04
    • Brief: Ultragenyx Enters Into Agreement To Sell Rare Pediatric Disease Priority Review Voucher For $210 Million

      07/10/2026 13:44
    • U.S. STOCKS ON THE MOVE-CoreWeave, StubHub, Ultragenyx

      18/09/2026 14:04

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.